Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Barlogie

Showing results (41-50 of 359) with videos related to

Pageof 36
Sort By:
American Journal of Clinical Oncology|June 1, 1991
Alpha-interferon combination therapy of resistant myelomaR Alexanian, B Barlogie, J Gutterman
Seminars in Oncology|December 12, 2001
Thalidomide in the management of multiple myelomaB Barlogie, G Tricot, E Anaissie
The New England Journal of Medicine|January 24, 1998
The systemic amyloidosesM Dhodapkar, B Barlogie, M Gertz
JAMA|November 25, 1992
Plasma cell dyscrasiasB Barlogie, R Alexanian, S Jagannath
Blood|October 9, 1998
Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestationsS Yaccoby, B Barlogie, J Epstein
European Journal of Haematology. Supplementum|January 1, 1989
Chemotherapy for resistant and relapsing multiple myelomaR Alexanian, B Barlogie, G Ventura
Current Opinion in Hematology|July 1, 1997
Advances in the treatment of multiple myelomaS Singhal, J Mehta, B Barlogie
American Journal of Hematology|December 1, 1985
Beta 2 microglobulin in multiple myelomaR Alexanian, B Barlogie, H Fritsche
Bone Marrow Transplantation|November 16, 2004
Cure of myeloma: hype or reality?A Fassas, J Shaughnessy, B Barlogie
FEBS Letters|January 30, 1971
Activation of calcium efflux by ADP and inorganic phosphateB Barlogie, W Hasselbach, M Makinose
Pageof 36

Showing results (41-50 of 359) with videos related to

Sort By:
Pageof 36
American Journal of Clinical Oncology|June 1, 1991
Alpha-interferon combination therapy of resistant myelomaR Alexanian, B Barlogie, J Gutterman
Seminars in Oncology|December 12, 2001
Thalidomide in the management of multiple myelomaB Barlogie, G Tricot, E Anaissie
The New England Journal of Medicine|January 24, 1998
The systemic amyloidosesM Dhodapkar, B Barlogie, M Gertz
JAMA|November 25, 1992
Plasma cell dyscrasiasB Barlogie, R Alexanian, S Jagannath
Blood|October 9, 1998
Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestationsS Yaccoby, B Barlogie, J Epstein
European Journal of Haematology. Supplementum|January 1, 1989
Chemotherapy for resistant and relapsing multiple myelomaR Alexanian, B Barlogie, G Ventura
Current Opinion in Hematology|July 1, 1997
Advances in the treatment of multiple myelomaS Singhal, J Mehta, B Barlogie
American Journal of Hematology|December 1, 1985
Beta 2 microglobulin in multiple myelomaR Alexanian, B Barlogie, H Fritsche
Bone Marrow Transplantation|November 16, 2004
Cure of myeloma: hype or reality?A Fassas, J Shaughnessy, B Barlogie
FEBS Letters|January 30, 1971
Activation of calcium efflux by ADP and inorganic phosphateB Barlogie, W Hasselbach, M Makinose
Pageof 36